Retatrutide Phase 2 and Phase 3: breaking records Retatrutide entered the picture with Phase 2 trial data that immediately captured attention
Take melatonin, discussed earlier
Systemic effects that have been reported in trials, or that are mechanistically expected from elevated GH and IGF-1, include: Water retention and mild edema , particularly in the hands, ankles, and face Tingling, numbness, or 'pins and needles' (paresthesia) , sometimes linked to fluid pressure on nerves Headache and facial flushing , often shortly after administration Joint aches or stiffness (arthralgia) Transient changes in blood glucose due to GH's counter-regulatory effect on insulin Fatigue, dizziness, or a feeling of light-headedness in some individuals It is important to be candid about the limits of this evidence
What were aiming to do is to epigenetically restore the animal and eventually the person, he says
No need to drink water